Matinas BioPharma Holdings Inc (MTNB)
0.6344
-0.08
(-10.65%)
USD |
NYAM |
Nov 14, 16:00
0.6306
0.00 (0.00%)
After-Hours: 20:00
Matinas BioPharma Holdings Cash from Financing (Quarterly): 9.189M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 9.189M |
| March 31, 2024 | 0.053M |
| December 31, 2023 | -0.001M |
| September 30, 2023 | -0.001M |
| June 30, 2023 | -0.001M |
| March 31, 2023 | -0.004M |
| December 31, 2022 | -0.005M |
| September 30, 2022 | -0.003M |
| June 30, 2022 | -0.006M |
| March 31, 2022 | 0.093M |
| December 31, 2021 | 0.0083M |
| September 30, 2021 | -0.0083M |
| June 30, 2021 | 0.1805M |
| March 31, 2021 | 6.784M |
| December 31, 2020 | 0.5496M |
| September 30, 2020 | 0.0542M |
| June 30, 2020 | 0.0037M |
| March 31, 2020 | 47.44M |
| December 31, 2019 | 0.0103M |
| September 30, 2019 | -0.0195M |
| June 30, 2019 | -0.167M |
| March 31, 2019 | 30.03M |
| December 31, 2018 | 8.359M |
| Date | Value |
|---|---|
| September 30, 2018 | 0.6425M |
| June 30, 2018 | 7.002M |
| March 31, 2018 | -0.1357M |
| December 31, 2017 | 0.3394M |
| September 30, 2017 | 0.5532M |
| June 30, 2017 | -0.051M |
| March 31, 2017 | 14.76M |
| December 31, 2016 | 0.0018M |
| September 30, 2016 | 7.007M |
| June 30, 2016 | -0.0008M |
| March 31, 2016 | -0.0113M |
| December 31, 2015 | 0.0038M |
| September 30, 2015 | -0.0699M |
| June 30, 2015 | 4.239M |
| March 31, 2015 | 4.283M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 13.03M |
| June 30, 2013 | 0.0863M |
| March 31, 2013 | 0.3854M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.0083M
Minimum
Sep 2021
47.44M
Maximum
Mar 2020
3.386M
Average
0.0083M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
| Equillium Inc | 0.091M |
| Tenon Medical Inc | 0.00 |
| Alphatec Holdings Inc | 6.694M |
| Merck & Co Inc | -2.425B |
| Madrigal Pharmaceuticals Inc | 7.462M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.106M |
| Cash from Investing (Quarterly) | -2.938M |
| Free Cash Flow | -17.87M |
| Free Cash Flow Per Share (Quarterly) | -0.6228 |
| Free Cash Flow Yield | -625.2% |